2921.44 | | Diphenylamine and its derivatives; salts thereof: | | | | |
2921.44.20 | 00 | Products described in additional U.S. note 3 to section VI | kg | 6.5% | Free (A+,AU,BH, CA,CL,D,E,IL,J, JO,MA,MX,P) 2.9% (SG) | 15.4¢/kg + 60% |
2921.45 | | 1-Naphthylamine ( α-Naphthylamine), 2-Naphthylamine ( β-Naphthylamine), and their derivatives; salts thereof: | | | | |
2921.45.60 | 00 | Products described in additional U.S. note 3 to section VI | kg | 6.5% | Free (A+,AU,BH, CA,CL,D,E,IL,J, JO,K,L,MA,MX, P) 2.9% (SG) | 15.4¢/kg + 60% |
2921.46.00 | 00 | Amfetamine (INN), benzfetamine (INN), dexamfetamine (INN), etilamfetamine (INN), fencamfamin (INN), lefetamine (INN), levamfetamine (INN), mefenorex (INN) and phentermine (INN); salts thereof | kg | Free | | 15.4¢/kg + 149.5% |
2921.49.45 | 00 | Products described in additional U.S. note 3 to section VI | kg | 6.5% | Free (A+,AU,BH, CA,CL,D,E,IL,J, JO,K,MA,MX, P) 2.9% (SG) | 15.4¢/kg + 60% |
2921.51 | | Aromatic polyamines and their derivatives; salts thereof: | | | | |
2921.51 | | o-, ¢/ p-Phenylenediamine, diaminotoluenes, and their derivatives; salts thereof: | | | | |
2921.51.30 | 00 | Products described in additional U.S. note 3 to section VI | kg | 6.5% | Free (A+,AU,BH, CA,CL,D,E,IL,J, JO,L,MA,MX, P) 2.9% (SG) | 15.4¢/kg + 60% |
2921.59.40 | 00 | Products described in additional U.S. note 3 to section VI | kg | 6.5% | Free (A+,AU,BH, CA,CL,D,E,IL,J, JO,K,L,MA,MX, P) 2.9% (SG) | 15.4¢/kg + 60% |
2922.19.60 | 00 | Products described in additional U.S. note 3 to section VI | kg | 6.5% | Free (A+,AU,BH, CA,CL,D,E,IL,J, JO,K,MA,MX, P) 2.9% (SG) | 15.4¢/kg + 50% |
2922.21.40 | 00 | Products described in additional U.S. note 3 to section VI | kg | 6.5% | Free (A+,AU,BH, CA,CL,D,E,IL,J, JO,L,MA,MX, P) 2.9% (SG) | 15.4¢/kg + 50% |
2922.29.10 | 00 | 2-Amino-6-chloro-4-nitrophenol; 2-Amino-4-chlorophenol; 2-Amino-4-chlorophenol hydrochloride; 2-Amino-p-cresol; 4-Amino-o-cresol; 6-Amino-2,4-dichloro-3-methylphenol; 2-(3-Amino-4-hydroxyphenylsulfonyl)ethanol; 2-Amino-4-nitrophenol; 2-Amino-4-nitrophenol, sodium salt; 2-Amino-5-nitrophenol; m-Aminophenol; 2-(4'-Aminophenoxy)ethylsulfate; 5-Chloro-2-(2',4'-dichlorophenoxy)aniline; 3,4-Dimethoxyphenethylamine (Homoveratrylamine); 2-Hydroxy-5-nitrometanilic acid; 4-Methoxymetanilic acid; 6-Methoxymetanilic acid; 4-Methoxy-m-phenylenediamine; 5-Methoxy-m-phenylenediamine sulfate; 6-(Methylamino)-1-naphthol-3-sulfonic acid; 7-(Methylamino)-1-naphthol-3-sulfonic acid; and 2-Methyl-p-anisidine | kg | 5.8% | Free (A+,AU,BH, CA,CL,D,E,IL,J, JO,K,L,MA,MX, P,SG) | 15.4¢/kg + 39% |
2922.29.61 | 00 | Products described in additional U.S. note 3 to section VI | kg | 6.5% | Free (A+,AU,BH, CA,CL,D,E,IL,J, JO,K,L,MA,MX, P) 2.9% (SG) | 15.4¢/kg + 50% |
2922.39.25 | 00 | Products described in additional U.S. note 3 to section VI | kg | 6.5% | Free (A+,AU,BH, CA,CL,D,E,IL,J, JO,K,MA,MX, P) 2.9% (SG) | 15.4¢/kg + 50% |
2922.43.10 | 00 | Products described in additional U.S. note 3 to section VI | kg | 6.5% | Free (A+,AU,BH, CA,CL,D,E,IL,J, JO,K,MA,MX, P) 2.9% (SG) | 15.4¢/kg + 50% |
2922.49.30 | 00 | Products described in additional U.S. note 3 to section VI | kg | 6.5% | Free (A+,AU,BH, CA,CL,D,E,IL,J, JO,K,MA,MX, P) 2.9% (SG) | 15.4¢/kg + 50% |
2922.50.14 | 00 | Cardiovascular drugs | kg | 6.5% | Free (A+,AU,BH, CA,CL,D,E,IL,J, JO,K,MA,MX, P,SG) | 15.4¢/kg + 65% |
2922.50.19 | 00 | Guaiacol derivatives | kg | 6.5% | Free (A,AU,BH,CA, CL,E,IL,J,JO, K,MA,MX, P,SG) | 15.4¢/kg + 79% |
2922.50.35 | 00 | Products described in additional U.S. note 3 to section VI | kg | 6.5% | Free (A+,AU,BH, CA,CL,D,E,IL,J, JO,K,MA,MX, P) 2.9% (SG) | 15.4¢/kg + 50% |
2923.20.10 | 00 | Purified egg phospholipids, pharmaceutical grade meeting requirements of the U.S. Food and Drug Administration, for use in intravenous fat emulsion | kg | Free | | 16.5¢/kg + 30% |
2924.11.00 | 00 | Acyclic amides (including acyclic carbamates) and their derivatives; salts thereof: | | | | |
2924.21 | | Cyclic amides (including cyclic carbamates) and their derivatives; salts thereof: | | | | |
2924.21 | | Ureines and their derivatives; salts thereof: | | | | |
2924.21.20 | 00 | Products described in additional U.S. note 3 to section VI | kg | 6.5% | Free (A+,AU,BH, CA,CL,D,E,IL,J, JO,K,L,MA,MX, P) 2.9% (SG) | 15.4¢/kg + 58% |